- Home
- Applications
- north america
- sars cov 2 insight research assay for sars cov 2
Show results for
Refine by
Sars Cov 2 Insight Research Assay For Sars Cov 2 Product Applications Near North America
12 applications found
This application note describes the utility of SRSLY in performing targeted sequence analysis of SAR-CoV-2 RNA-Seq libraries were generated with SRSLY within 3 hours. Subsequent enrichment of viral sequences can be performed with a user-preferred hybridization-based panel. ...
ByClaret Bioscience based in Santa Cruz, CALIFORNIA (USA)
The COVID-19 pandemic has hit particularly hard the public transportation sector. Highly attended means of public transport and people’s mobility present an increasing risk factor for the spread of pathogens such as the SARS-CoV-2 virus. Thus the need to effectively and thoroughly disinfect the surfaces of the actual means of transportation (planes, trains, buses) and the communal areas such as hall or waiting ...
By99 Technologies S.A. based in Lugano, SWITZERLAND
The rapid emergence of the COVID-19 pandemic has thrust tools like next generation sequencing (NGS) applications to the forefront of the global public health response. NGS is a sensitive and specific tool that is being used to detect the presence of the SARS-CoV-2 virus from a variety of clinical and environmental samples. Tracking SARS-CoV-2 viral strain evolution is critical for monitoring new regional outbreaks, contact tracing, infection control and verifying the performance of front-line RT-PCR diagnostic ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
The fast track to accurate results. Point-of-Care testing has become increasingly important in recent years as a patient-oriented or general close proximity testing method to generate rapid results. Especially in emergency medical care, where a quick diagnosis can be crucial, PoC has become indispensable. Our PoC devices are effectively decentralizing diagnostics, allowing rapid results basically anywhere at any time. Thus, this quick and close testing for markers of interest dramatically improves access, outcome, ...
ByLRE Medical based in Noerdlingen, GERMANY
As the COVID-19 pandemic continues, the SARS-CoV-2 virus is likely to become endemic with emerging novel variants, some of them seasonal. Updates to the various vaccines will be required, as will a range of anti-virals with a variety of mechanisms of action, for use in early infection and in hospitalizated patients, much like oseltamivir (Tamiflu) is used in certain populations for seasonal ...
ByCyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA)
Cyrus’s protein biochemistry capabilities include advanced selection methodologies in both yeast and mammalian cell systems. These tools can interrogate large numbers of mutations in cell surface receptors and many globular proteins, offering a unique path forward for protein optimization based on high quality, physiologically-relevant data in eukaryotic or – specifically – human ...
ByCyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA)
Simple, fast, and effective device sanitization designed for healthcare. ...
ByCleanSlate UV based in Buffalo, NEW YORK (USA)
At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. The severity and rapid spread of COVID-19 (caused by SARS-CoV-2), resulted in a global pandemic declared by the World Health Organization in March 2020. The virus has spread to more than 100 countries, including the United ...
ByNovavax based in Gaithersburg, MARYLAND (USA)
Rapid and efficient screening tools are an essential step in the global fight against COVID-19 and key to ensuring a safe return to daily life and social interactions. Today, nucleotide-based testing (RT-PCR) is the gold standard for diagnosing the disease. But, while sensitive, these tests are limited by long turnaround times, high costs and a typically invasive and uncomfortable nature of ...
ByAbionic SA based in Epalinges, SWITZERLAND
Recently, the outbreak of the new coronavirus infection in China has become one of the world’s most pressing healthcare issues. Due to the absence of fast, accurate, and timely methods of disease detection, millions of families are quarantined at home. Airports and high-speed train stations are closed. Hospitals are full of possible coronavirus patients waiting for diagnosis. Fortunately, these situations have the potential to be completely ameliorated with our novel technologies. Combining the ...
ByOnsiteGene Inc. based in San Diego, CALIFORNIA (USA)
Nanoscale air decontamination for hospitals, clinics and laboratories. Genano Technology is scientifically proven to capture nano sized particles and eliminate 99,999% of microbes from indoor air. ...
ByGenano Industrial Air Purification Solutions - Genano Ltd. based in Espoo, FINLAND
SARS-CoV-2 currently has the world in its grasp. A quick, non-invasive test to identify an infection would be a tremendous step forward. There is a high probability that this disease can be detected in the exhaled breath but also monitoring the impact of treatment or medication in exhaled breath is highly relevant. IONICON PTR-TOF systems have become the de-facto standard for real-time breath analysis. Learn what they offer for COVID-19 detection in ...
ByIonicon Analytik Ges.m.b.H. based in Innsbruck, AUSTRIA